medigraphic.com
SPANISH

Revista Mexicana de Cardiología

ISSN 0188-2198 (Print)
En 2019, la Revista Mexicana de Cardiología cambió a Cardiovascular and Metabolic Science

Ver Cardiovascular and Metabolic Science


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2003, Number 1

<< Back Next >>

Rev Mex Cardiol 2003; 14 (1)

Surgical treatment of Ebstein´s disease. Experience in Hospital de Cardiología del Centro Médico Nacional Siglo XXI

Villanueva RF, Careaga RG, Argüero SR
Full text How to cite this article

Language: Spanish
References: 16
Page: 16-20
PDF size: 67.33 Kb.


Key words:

Ebstein´s disease, valve reconstruction, tricuspid valve.

ABSTRACT

Objective: To determine the type of surgical handling carried out for the treatment of the patients with Ebstein´s disease in a cardiologic center of third level of attention. Material and methods: The clinical file of the patients was revised with Ebstein´s disease tried in the division of cardiothoracic surgery of our hospital between January of 1997 and December of the 2001, with the purpose of obtaining age, sex, symptoms and functional class to the entrance, cabinet method used for the diagnosis, concomitant heart disease, surgical technique employed, length of stay in intensive care unit, complications, in-hospital stay and causes of death in the event of existing the same one. Results: Eight patients were included, with an age 13.3 year-old average, with relationship man woman of 1:1. The present symptom in all the patients was the progressive dyspnea. The echocardiogram was used in all the cases for carrying out the I diagnose and pursuit. The class functional III preoperatory prevailed. The atrial septal defect was the most frequent concomitant cardiopathy. The surgical correction that was used with more frequency in our service is the tricuspid valve reconstruction according to the surgical circumstances. The stay average in the unit intensive care was of 4.8 days. The flutter headphone is the most frequent postoperative complication in these patients. The average of total stay in the hospital is of 17.3 days. There was 1 death caused by refractory arrhythmia. Conclusions: The treatment surgical conservative is the best therapeutic option for this pathology. The tricuspid valve reconstruction used in this therapy variety has given good result in this Hospital Center.


REFERENCES

  1. Radford DJ, Graff RF, Nielson GH. Diagnosis and natural history of Ebstein’s anomaly. Br Heart J 1985; 54: 517-22.

  2. Anderson KR, Zuberbuhler JR, Anderson RH et al. Morphologic spectrum of Ebstein’s anomaly of the heart. Mayo Clin Proc 1979; 54: 174-180.

  3. Mair DD, Seward JB, Driscoll DJ, Danielson GK. Surgical repair of Ebstein’s anomaly: Selection of patients and early and late operative results. Circulation 1985; 72(Suppl. 2): II-70-76.

  4. Gentles TL, Calder AL, Clarkson PM, Neutze JM. Predictors of long-term survival with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol 1992; 69: 377-81.

  5. Shiina A, Seward JB, Edwards WD et al. Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Coll Cardiol 1984; 3: 356-370.

  6. Schreiber C, Cook A, Ho SY, Augustin N, Anderson RH. Morphologic spectrum of Ebstein’s malformation: Revisitation relative to surgical repair. J Thorac Cardiovasc Surg 1999; 117: 148-5.

  7. Carpentier A, Chauvaud S, Mace L, Relland J, Mihaileanu S, Marino JP, Abry B, Guibourt P. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg 1988; 96: 92-101.

  8. Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, Allan L, Nihoyannopoulos P, Somerville J, Deanfield JE. Ebstein’s anomaly: Presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23: 170-76.

  9. Leung MP, Baker EJ, Anderson RH et al. Cineangiographic spectrum of Ebstein’s malformation: its relevance to clinical presentation and outcome. J Am Coll Cardiol 1988; 11: 154-161.

  10. Yetman AT, Freedom RM, McCrindle BW. Outcome in cyanotic neonates with Ebstein’s anomaly. Am J Cardiol 1998; 81: 749-54.

  11. Danielson GK, Driscoll DJ, Mair DD, Warnes CA. Operative treatment of Ebstein’s anomaly. J Thorac Cardiovasc Surg 1992; 104: 1195-1202.

  12. Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RKH, Deanfield JE. Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol 1992; 19: 1041-46.

  13. Pavlova M, Fouron JC, Drblink SP, van Doesburg NH, Bigras JL, Smallhorn J, Harder J, Robertson M. Factors affecting the prognosis of Ebstein’s anomaly during fetal life. Am Heart J 1998; 135: 1081-85.

  14. Reddy VM, McElhinney DB, Silverman NH, Marianeschi SM, Hanley FL. Partial biventricular repair for complex congenital heart defects: An intermediate option for complicated anatomy or functional borderline right complex heart. J Thorac Cardiovasc Surg 1998; 116: 21-27.

  15. Saxena A, Fong LV, Tristan M, Ackery DM, Keeton BR. Left ventricular function in patients 20 years of age with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol 1991; 67: 217-19.

  16. Schrieber C, Cook A, Ho SY et al. Morphologic spectrum of Ebstein’s malformation: revisitation relative to surgical repair. J Thorac Cardiovasc Surg 1999; 117: 148-15.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cardiol. 2003;14